GSD1a – Patient Worthy

https://unsplash.com/photos/8ztH-7lj8ag

DCCR Tablets for GSD1A Granted Orphan Drug Status

Post author:Jessica Lynn
Post published:June 11, 2021
Post category:Glycogen Storage Disease Type I

In a news release from June 2, 2021, biopharmaceutical company Soleno Therapeutics, Inc. ("Soleno") shared an exciting update. The company's investigational treatment, DCCR (diazoxide choline) Extended-Release tablets, received Orphan Drug…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More